Media Thread, page-16912

lol gee how’s it going to look for old Hopper if this does pan out a certain way?
Had iNKT, loses control, enters into collab and sees data, can’t regain control, panic buys another cell therapy, watches iNKT sail past in value.
You do present some interesting points though, would imagine if there was truth to any of it, our EV’s wouldn’t be so similar?
ALA hardly trading like a company that’s miles away from IND and 4 years behind a co bearing PH2.
They have outsourced everything, hence the slower progress, but more than acceptable cash burn. But at least we can say with certainty our next raise will be at a much higher price than the last one, tight register likely means another cornerstone investor as well. Imagine having an MD that actually cares about its investors?
All these scientists and 17 FDA approved drugs, but still only have bell potter flogging it to more mums and dads. It’s impossible to say that with this register there is little if any smart money here.